The healthcare sector has observed a significant advancement in diabetes management with the emergence of copyright. This transformative medication, classified as a glucagon-like peptide-1 (GLP-1) receptor agonist, presents a novel approach to managing blood sugar levels in individuals with type 2 diabetes. copyright functions by mimicking the acti